MariMed Statistics

Total Valuation

MariMed has a market cap or net worth of CAD 46.83 million. The enterprise value is 168.50 million.

Market Cap	46.83M
Enterprise Value	168.50M

Important Dates

The next confirmed earnings date is Wednesday, May 13, 2026.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	398.91M
Shares Outstanding	n/a
Shares Change (YoY)	+2.90%
Shares Change (QoQ)	+0.68%
Owned by Insiders (%)	10.67%
Owned by Institutions (%)	2.26%
Float	332.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.21
PB Ratio	0.53
P/TBV Ratio	3.20
P/FCF Ratio	5.23
P/OCF Ratio	4.44
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.94, with an EV/FCF ratio of 18.83.

EV / Earnings	-8.48
EV / Sales	0.77
EV / EBITDA	10.94
EV / EBIT	n/a
EV / FCF	18.83

Financial Position

The company has a current ratio of 1.00, with a Debt / Equity ratio of 1.32.

Current Ratio	1.00
Quick Ratio	0.30
Debt / Equity	1.32
Debt / EBITDA	7.55
Debt / FCF	13.08
Interest Coverage	-0.31

Financial Efficiency

Return on equity (ROE) is -20.32% and return on invested capital (ROIC) is -1.61%.

Return on Equity (ROE)	-20.32%
Return on Assets (ROA)	-0.71%
Return on Invested Capital (ROIC)	-1.61%
Return on Capital Employed (ROCE)	-1.63%
Weighted Average Cost of Capital (WACC)	7.99%
Revenue Per Employee	253,049
Profits Per Employee	-22,932
Employee Count	866
Asset Turnover	0.78
Inventory Turnover	2.91

Taxes

In the past 12 months, MariMed has paid 4.93 million in taxes.

Income Tax	4.93M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.67% in the last 52 weeks. The beta is 1.15, so MariMed's price volatility has been higher than the market average.

Beta (5Y)	1.15
52-Week Price Change	-16.67%
50-Day Moving Average	0.11
200-Day Moving Average	0.15
Relative Strength Index (RSI)	58.90
Average Volume (20 Days)	55,927

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.07

Income Statement

In the last 12 months, MariMed had revenue of CAD 219.14 million and -19.86 million in losses. Loss per share was -0.05.

Revenue	219.14M
Gross Profit	79.36M
Operating Income	-3.20M
Pretax Income	-14.89M
Net Income	-19.86M
EBITDA	12.58M
EBIT	-3.20M
Loss Per Share	-0.05

Balance Sheet

The company has 12.18 million in cash and 117.04 million in debt, giving a net cash position of -104.86 million.

Cash & Cash Equivalents	12.18M
Total Debt	117.04M
Net Cash	-104.86M
Net Cash Per Share	n/a
Equity (Book Value)	88.76M
Book Value Per Share	0.18
Working Capital	305,760

Cash Flow

In the last 12 months, operating cash flow was 10.55 million and capital expenditures -1.60 million, giving a free cash flow of 8.95 million.

Operating Cash Flow	10.55M
Capital Expenditures	-1.60M
Depreciation & Amortization	15.74M
Net Borrowing	-6.25M
Free Cash Flow	8.95M
FCF Per Share	n/a

Margins

Gross margin is 36.22%, with operating and profit margins of -1.46% and -9.06%.

Gross Margin	36.22%
Operating Margin	-1.46%
Pretax Margin	-6.80%
Profit Margin	-9.06%
EBITDA Margin	5.74%
EBIT Margin	-1.46%
FCF Margin	4.08%

Dividends & Yields

MariMed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.90%
Shareholder Yield	-2.90%
Earnings Yield	-42.41%
FCF Yield	19.11%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MariMed has an Altman Z-Score of 0.05 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.05
Piotroski F-Score	2